Price controls on prescriptions could backfire, hurt sick seniors

Two in three Medicare beneficiaries live with multiple chronic diseases. A Trump administration proposal could make it harder for them to manage their conditions.
The Department of Health and Human Services is considering sweeping changes to the way Medicare pays for potent, physician-administered medicines. HHS officials claim they can cut costs by imposing price controls on these drugs.
In the long run, this price-capping scheme would reduce innovation and chronic disease patien